Prediction of Tumor Response to Neoadjuvant Therapy in Patients with Esophageal Cancer with Use of 18F FDG PET: A Systematic Review

被引:131
作者
Kwee, Robert M. [1 ]
机构
[1] Maastricht Univ, Med Ctr, Dept Radiol & Nucl Med, NL-6202 AZ Maastricht, Netherlands
关键词
POSITRON-EMISSION-TOMOGRAPHY; SQUAMOUS-CELL CARCINOMA; STANDARDIZED UPTAKE VALUE; ESOPHAGOGASTRIC JUNCTION; PATHOLOGICAL RESPONSE; PREOPERATIVE CHEMORADIATION; METABOLIC-ACTIVITY; INDUCTION CHEMORADIATION; COMPUTED-TOMOGRAPHY; FREE SURVIVAL;
D O I
10.1148/radiol.09091324
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To systematically review the accuracy of fluorine 18 ((18) F) fluorodeoxyglucose (FDG) positron emission tomography (PET) in the prediction of tumor response to neoadjuvant therapy in patients with esophageal cancer. Materials and Methods: The MEDLINE and EMBASE databases were systematically searched for relevant studies. Methodologic quality of the included studies was assessed. Sensitivities and specificities of F-18 FDG PET in individual studies were calculated and underwent meta-analysis with a random effects model. A summary receiver operating characteristic curve (sROC) was constructed with the Moses-Shapiro-Littenberg method. A chi(2) test was performed to test for heterogeneity (defined as P < .10). Potential sources for heterogeneity were explored by assessing whether certain covariates significantly (P < .05) influenced the relative diagnostic odds ratio. Results: Twenty reports, comprising a total of 849 patients with esophageal cancer, were included. Overall, the studies were of moderate methodologic quality. Sensitivity and specificity of F-18 FDG PET ranged from 33% to 100% and from 30% to 100%, respectively, with pooled estimates of 67% (95% confi dence interval: 62%, 72%) and 68% ( 95% confi dence interval: 64%, 73%), respectively. The area under the sROC curve was 0.7815. There was significant heterogeneity in both the sensitivity and specificity of the included studies (P < .0001). Spearman rho between the logit of sensitivity and the logit of 1-specificity was 0.086 (P = .719), which suggested that there was no threshold effect. Studies performed outside of the United States and studies of higher methodologic quality yielded significantly higher overall accuracy. Conclusion: On the basis of current evidence, 18 F FDG PET should not yet be used in routine clinical practice to guide neoadjuvant therapy decisions in patients with esophageal cancer. (C) RSNA, 2010
引用
收藏
页码:707 / 717
页数:11
相关论文
共 50 条
  • [1] The predictive value of 18F-FDG PET for pathological response of primary tumor in patients with esophageal cancer during or after neoadjuvant chemoradiotherapy: a meta-analysis
    Cong, Lihong
    Wang, Shikun
    Gao, Teng
    Hu, Likuan
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 46 (12) : 1118 - 1126
  • [2] Locally advanced esophageal adenocarcinoma: Response to neoadjuvant chemotherapy and survival predicted by [18F]FDG-PET/CT
    Kauppi, Juha T.
    Oksala, Niku
    Salo, Jarmo A.
    Helin, Heikki
    Karhumaki, Lauri
    Kemppainen, Jukka
    Sihvo, Eero I.
    Rasanen, Jari V.
    ACTA ONCOLOGICA, 2012, 51 (05) : 636 - 644
  • [3] [18F]-FDG PET in anal canal cancer: a systematic review and meta-analysis
    Mirshahvalad, Seyed Ali
    Mesci, Aruz
    Murad, Vanessa
    Kohan, Andres
    Ortega, Claudia
    Veit-Haibach, Patrick
    Metser, Ur
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 51 (01) : 258 - 277
  • [4] Prediction of Response to Neoadjuvant Chemotherapy and Radiation Therapy with Baseline and Restaging 18F-FDG PET Imaging Biomarkers in Patients with Esophageal Cancer
    Beukinga, Roelof J.
    Hulshoff, Jan Binne
    Mul, Veronique E. M.
    Noordzij, Walter
    Kats-Ugurlu, Gursah
    Slart, Riemer H. J. A.
    Plukker, John T. M.
    RADIOLOGY, 2018, 287 (03) : 983 - 992
  • [5] 18F-FDG PET/CT parameters for prediction of response to neoadjuvant therapy and prognosis in rectal cancer
    Ebinc, Senar
    Guzel, Yunus
    Oruc, Zeynep
    Komek, Halil
    Kalkan, Ziya
    Can, Canan
    Tasdemir, Bekir
    Urakci, Zuhat
    Kaplan, Muhammet Ali
    Kucukoner, Mehmet
    Isikdogan, Abdurrahman
    NUCLEAR MEDICINE COMMUNICATIONS, 2023, 44 (01) : 81 - 90
  • [6] Spatial-Temporal [18F]FDG-PET Features for Predicting Pathologic Response of Esophageal Cancer to Neoadjuvant Chemoradiation Therapy
    Tan, Shan
    Kligerman, Seth
    Chen, Wengen
    Lu, Minh
    Kim, Grace
    Feigenberg, Steven
    D'Souza, Warren D.
    Suntharalingam, Mohan
    Lu, Wei
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 85 (05): : 1375 - 1382
  • [7] The Role of [18F]FDG PET/CT in Monitoring of Therapy Response in Lung Cancer
    Ayeni, Akinwale
    Evbuomwan, Osayande
    Vangu, Mboyo-Di-Tamba Willy
    SEMINARS IN NUCLEAR MEDICINE, 2025, 55 (02) : 175 - 189
  • [8] Value of 18F-FDG PET for Predicting Response to Neoadjuvant Therapy in Rectal Cancer: Systematic Review and Meta-Analysis
    Maffione, Anna Margherita
    Marzola, Maria Cristina
    Capirci, Carlo
    Colletti, Patrick M.
    Rubello, Domenico
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2015, 204 (06) : 1261 - 1268
  • [9] 18F FDG-PET/CT evaluation of histological response after neoadjuvant treatment in patients with cancer of the esophagus or gastroesophageal junction
    Gabrielson, Stefan
    Sanchez-Crespo, Alejandro
    Klevebro, Fredrik
    Axelsson, Rimma
    Tsai, Jon Albert
    Johansson, Ove
    Nilsson, Magnus
    ACTA RADIOLOGICA, 2019, 60 (05) : 578 - 585
  • [10] Baseline 18F-FDG PET/CT as predictor of the pathological response to neoadjuvant therapy in esophageal cancer A retrospective study
    Domachevsky, Liran
    Kashtan, Hanoch
    Brenner, Baruch
    Nidam, Meital
    Morgenstern, Sara
    Kundel, Yulia
    Groshar, David
    Bernstine, Hanna
    MEDICINE, 2018, 97 (49)